Botox 200 unit vials

Ended Awarded Last action

Contract number
SPE2DR26FHCG9
Awardee
Awarding agency
Obligated
$52,813

Award facts

Contract value 100% obligated
$52,812.80 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $52,812.80 delivery order to DMS Pharmaceutical Group Inc. on May 20, 2026, for BOTOX 200 Unit Vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).

DMS Pharmaceutical is a woman-owned small business and the sole regional prime vendor under PPV-G GEN V, holding a single-award indefinite delivery contract (SPE2DX) with a $499.999 billion ceiling and ultimate completion through December 31, 2036. Place of performance is Park Ridge, IL. The delivery order carries an ultimate completion date of June 11, 2026, and is priced on a firm fixed-price basis. The order is not issued under any set-aside.

Quick answers

Who was awarded contract SPE2DR26FHCG9?

SPE2DR26FHCG9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 20, 2026.

How much is contract SPE2DR26FHCG9 worth?

The government has obligated $52,813 on SPE2DR26FHCG9.

Is contract SPE2DR26FHCG9 an order under another contract?

Yes. SPE2DR26FHCG9 is a delivery order under SPE2DR25D9205, an indefinite delivery contract.

Was contract SPE2DR26FHCG9 competed?

The extent of competition for SPE2DR26FHCG9 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award